Financial Freedom LLC’s Labcorp LH Stock Holding History

Financial Freedom LLC’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24	Closed	-$6.4K	–	269
2026 Q1	$6.4K	Buy	+24	New	+$6.5K	﹤0.01%	349

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Financial Freedom LLC's LH Position: Q2 2026 in Review

Financial Freedom LLC sold out of Labcorp (LH) in Q2 2026, closing a stake of 24 shares — an estimated $6.4K sold.

Financial Freedom LLC first reported a position in LH in Q1 2026 and held it in 1 quarter. The position peaked at $6.4K in Q1 2026. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Financial Freedom LLC reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
Financial Freedom LLC sold 24 Labcorp shares in Q2 2026, an estimated $6.4K.
Financial Freedom LLC first reported a position in Labcorp in Q1 2026 and held it in 1 quarter.
Financial Freedom LLC's Labcorp position peaked at $6.4K in Q1 2026.
1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.